Intellectual Property India Publishes Patent Application for 'Hyaluronidase Enzyme Formulations For High Volume Administration' Filed by Halozyme, Inc.

MUMBAI, India, Aug. 8 -- Intellectual Property India has published a patent application (202517068412 A) filed by Halozyme, Inc., San Diego, on July 17, for 'hyaluronidase enzyme formulations for high volume administration.'

Inventor(s) include Kang, David, W.; Connor, Robert, J.; Nekoroski, Tara; Leadens, Todd, J., II; Frantz, Baylor; Beacher, Scott; Swanson, Kevin; and Travanty, Mike.

The application for the patent was published on Aug. 8, under issue no. 32/2025.

According to the abstract released by the Intellectual Property India: "In one aspect, the present disclosure provides a formulation comprising a hyaluronidase enzyme and a therapeutically effective amount of an active ingredient. In another aspect, the present disclosure provides a method of administering a high volume of the formulation in a single administration to treat a disease or disorder in a subject."

The patent application was internationally filed on Dec. 22, 2023, under International application No.PCT/US2023/085807.

Disclaimer: Curated by HT Syndication.